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Abstract
Background: Multidrug-resistant Gram-negative bacteria (MDRGN), including extended-spectrum β-lactamases
(ESBLs) and multidrug-resistant glucose-nonfermenting Gram-negative bacilli (nonfermenters), have emerged and
spread throughout Southeast Asia.
Methods: We reviewed and summarized current critical knowledge on the epidemiology and molecular
characterization of MDRGN in Southeast Asia by PubMed searches for publications prior to 10 March 2016 with the
term related to “MDRGN definition” combined with specific Southeast Asian country names (Thailand, Singapore,
Malaysia, Vietnam, Indonesia, Philippines, Laos, Cambodia, Myanmar, Brunei).
Results: There were a total of 175 publications from the following countries: Thailand (77), Singapore (35), Malaysia
(32), Vietnam (23), Indonesia (6), Philippines (1), Laos (1), and Brunei (1). We did not find any publications on
MDRGN from Myanmar and Cambodia. We did not include publications related to Shigella spp., Salmonella spp.,
and Vibrio spp. and non-human related studies in our review. English language articles and abstracts were included
for analysis. After the abstracts were reviewed, data on MDRGN in Southeast Asia from 54 publications were further
reviewed and included in this study.
Conclusions: MDRGNs are a major contributor of antimicrobial-resistant bacteria in Southeast Asia. The high
prevalence of ESBLs has been a major problem since 2005 and is possibly related to the development of
carbapenem resistant organisms in this region due to the overuse of carbapenem therapy. Carbapenem–resistant
Acinetobacter baumannii is the most common pathogen associated with nosocomial infections in this region
followed by carbapenem-resistant Pseudomonas aeruginosa. Although Southeast Asia is not an endemic area for
carbapenem-resistant Enterobacteriaceae (CRE), recently, the rate of CRE detection has been increasing. Limited
infection control measures, lack of antimicrobial control, such as the presence of active antimicrobial stewardship
teams in the hospital, and outpatient antibiotic restrictions, and travel throughout this region have likely
contributed to the increase in MDRGN prevalence.
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Background
The Southeast Asian region has a history of high
prevalence of multidrug-resistant Gram-negative
bacteria (MDRGN) including extended-spectrum β-
lactamases (ESBLs) and multidrug-resistant (MDR)
glucose-nonfermenting Gram-negative bacilli (nonfermen-
ters), especially Acinetobacter baumannii and Pseudo-
monas aeruginosa [1, 2]. In addition, carbapenem-resistant
organisms (CRO) have recently emerged and spread to
Southeast Asia [3]. The epidemiology and molecular char-
acteristics of MDRGN have been reported from Brunei,
Indonesia, Laos, Malaysia, the Philippines, Singapore,
Thailand, and Vietnam [1, 3–8]. Carbapenem–resistant
Acinetobacter baumannii (CRAB) is the most common
CRO associated with nosocomial infection in this region
followed by carbapenem-resistant Pseudomonas aeruginosa
(CRPA) [3–6]. Although Southeast Asia is not an endemic
area of carbapenem-resistant Enterobacteriaceae (CRE), re-
cently, the rate of CRE detection has been increasing [3, 4].
CREs are particularly concerning as these organisms are
often disseminated by plasmids and have the potential to
spread between patients causing outbreaks in several
countries [1, 3–6]. We review and summarize current
critical knowledge on the epidemiology and molecular
characteristics of MDRGN organisms in Southeast Asia.
Methods
Literature search, definition and selection strategy
PubMed searches were performed for publications prior
to 10 March 2016 with the term related to “MDRGN
definition” combined with specific Southeast Asian
country names (Thailand, Singapore, Malaysia, Vietnam,
Fig. 1 Prevalence (%) of extended-spectrum β-lactamases (ESBLs) and carbapenem-resistant organisms by country in Southeast Asia, adopted
from reference 5 (COMPACT II study). The organisms were obtained during April – July 2010, from 5 Centers in Asia-Pacific countries including
New Zealand (data not shown), the Philippines (3 centers, 16 A. baumannii isolates, 90 P. aeruginosa isolates, 70 Enterobacteriaceae isolates),
Singapore (3 centers, 21 A. baumannii isolates, 120 P. aeruginosa isolates, 96 Enterobacteriaceae isolates), Thailand (10 centers, 59 A. baumannii
isolates, 296 P. aeruginosa isolates, 239 Enterobacteriaceae isolates) and Vietnam (3 centers, 19 A. baumannii isolates, 90 P. aeruginosa isolates, 71
Enterobacteriaceae isolates). There are small numbers of A. baumannii isolations tested from reference 5. Prevalence of CRAB in other studies are
#70.5-91 % (Singapore) [6, 43, 44], ¶46.7-80 % (Thailand) [29–31] and §more than 90 % (Vietnam) [48]. *Recent studies have been shown the increasing
prevalence of CRE in Singapore and Thailand [1, 3, 4, 6, 22]. Abbreviation; CR, carbapenem–resistant; CRE, carbapenem-resistant Enterobacteriaceae; ESBLs,
extended-spectrum β-lactamases
Suwantarat and Carroll Antimicrobial Resistance and Infection Control  (2016) 5:15 Page 2 of 8
Indonesia, Philippines, Laos, Cambodia, Myanmar,
Brunei). For epidemiologic purposes, we defined
MDRGN as Gram-negative bacteria that are resistant to
at least 3 classes of antimicrobial agents [1, 2]. We
searched the terms Multidrug-resistant gram-negative
bacteria, MDR Gram-negative bacteria, ESBL, KPC,
NDM, VIM, IMP, MBL, CRE, Acinetobacter,
Pseudomonas.
Results and Discussion
There were a total of 175 publications from the follow-
ing countries: Thailand (77), Singapore (35), Malaysia
(32), Vietnam (23), Indonesia (6), Philippines (1), Laos
(1), and Brunei (1). We did not find any publications on
MDRGN from Myanmar and Cambodia. We did not in-
clude publications related to Shigella spp., Salmonella
spp., and Vibrio spp. and non-human related studies in
our review.
English language articles and abstracts were included
for analysis. After the abstracts were reviewed, data on
MDRGN in Southeast Asia from 54 publications were
further reviewed and included in this study.
Epidemiology and molecular characteristic of MDRGN in
Southeast Asia
Overall, the prevalence of MDRGN bacteria varies by
countries, institutions, and time of the studies. There
were some publications on the prevalence of MDRGN
bacteria in Southeast Asia but the studies’ limitations
were related to small numbers of isolates tested in each
country. The Comparative Activity of Carbapenem
Testing (COMPACT) II study during April – July 2010
revealed a high prevalence of MDRGNs including ESBLs
and CRO in Southeast Asia (Fig. 1) [5]. This study
surveyed the carbapenem susceptibility against 1260
major Gram-negative organisms isolated from hospital-
ized patients at 20 centers in 5 Asia-Pacific countries
(New Zealand, the Philippines, Singapore, Thailand and
Vietnam). Amongst Enterobacteriaceae isolates, 39.4 %
of 436 isolates tested (Escherichia coli, Klebsiella pneu-
moniae, Klebsiella oxytoca and Proteus mirabilis) were
positive for ESBL production, with the highest rate in
Vietnam (55.1 %) followed by Thailand (45.2 %). There
were no ESBLs found in clinical isolates from New
Zealand. ESBL-producers were more commonly isolated
from intensive care unit (ICU) patients than non-ICU
patients in the Philippines (58.8 % vs. 27.5 %) and
Vietnam (81.0 % vs. 43.8 %). Among CRO isolates, the
CRAB detection rate among clinical isolates was 73 %
followed by a CRPA detection rate of 29.8 %. In contrast,
the rate of CRE detection was only 2.8 % [5]. In a separ-
ate report, Menders et al. [1] reported the results of the
Regional Resistance Surveillance program susceptibility
rates from 12 Asia-Pacific countries (APAC) in 2011. Most
of this surveillance data came from Indonesia, the
Philippines, and Thailand and a small sampling of data
came from Malaysia and Singapore. Among 310 strains,
96 isolates from Indonesia, the Philippines, and Thailand
expressed the ESBL-resistance phenotype; the ESBL pro-
duction rate in E. coli was 59.4 % (APAC regional rate,
48.0 %) and the highest rate occurred among Indonesian
isolates (71.0 %). Also, the prevalence of ESBL-production
in Klebsiella was 46.7 % (APAC rate, 47.0 %) and the
highest rate occurred among Indonesian isolates (64.0 %).
The CTX-M-series enzymes have become the dominant
ESBL-type in this region [1, 9, 10].
The OXA-type carbapenemase gene, blaOXA-23 is a
predominant β-lactamase gene among A. baumannii
isolates in this region and belongs to global clone 2
[11, 12]. Two global clones of A. baumannii have been
reported (global clone 1 and global clone 2) worldwide
[10]. Global clone 2 corresponds to clonal complex 92
(CC92) in the multilocus sequence typing (MLST) scheme
of Bartual et al. and Woodford et al. [11, 12]. Global clone
2 has emerged in Europe and spread throughout A.
baumannii isolates in Asian countries, including South
Korea and China and Australia [11]. In addition, the
blaOXA-40, and blaOXA-58 have been reported in a few A.
baumannii isolates in this region [3, 6, 11, 12]. In P.
aeruginosa, carbapenem resistance is multifactorial and
involves non-carbapenamase mechanisms such as porin
changes (OprD gene mutation) and a combination of
efflux pump and AmpC β-lactamase hyperproduction.
Metallo β-lactamase-production (MBL) has been reported
in CRPA and includes IMP-type metallo-β-lactamase
(blaIMP) and Verona integron-mediated MBL (blaVIM)
[3, 6, 11–15]. Among CRE isolates, New Delhi MBLs
(NDM) have emerged and predominate in several
countries in this region [6, 16–20]. Other MBL genes
such as blaIMP, blaVIM and blaOXA have been reported in
some countries [6, 19, 21–23]. Klebsiella pneumoniae car-
bapenamase (KPC)-producing Enterobacteriaceae is less
common in Southeast Asia and officially reported only
from Singapore and Thailand [22, 24]. This finding is in
contrast to data from North America and Europe where
blaKPC is the most common β-lactamase gene reported
among CRE isolates [6, 22, 24]. In addition, non-
carbapenamase mechanism such as outer member protein
changes (Omp gene mutation) and AmpC β-lactamase
hyperproduction are common mechanisms of resistance
in CRE isolates [3, 6, 25].
Thailand
The majority of epidemiology and molecular studies of
MDRGN in Thailand were performed on isolates from
hospitalized patients [1, 5, 10, 26]. Recently, a cross
sectional study from an academic tertiary care hospital
in Thailand between February and May 2012 revealed a
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high prevalence of MDRGN (48.8 %). The percentage of
MDRGN was 37.8 % for ESBL-producers, 39.3 % for
CRPA, and 88.7 % for CRAB [10]. Infections caused by
MDRGN were associated with admission to medical
wards, were of respiratory tract origin and hospital onset
of infection. Using multivariate analysis, the only signifi-
cant risk factor of MDRGN infection was previous
antibiotic use within 1 year (adjusted odds ratio 6.818,
95 % CI = 1.337–34.770) [10]. ESBLs of the blaCTX-M type
are highly endemic in Thailand, especially among
hospital-associated isolates [10, 26]. Kiratisin et al. [10],
performed a molecular study on 362 isolates of ESBL-
producing E. coli (n = 235) and ESBL-producing K.
pneumoniae (n = 127) collected from patients with
hospital-associated infection at two major university
hospitals in Thailand from December 2004 to May
2005. A total of 87.3 % of isolates carried several bla
genes. The prevalence of blaCTX-M was 99.6 % for
ESBL-producing E. coli (CTX-M-14, -15, -27, -40, and
-55) and 99.2 % for ESBL-producing K. pneumoniae
(CTX-M-3, -14, -15, -27, and -55). Up to 77.0 and 71.7 %
of ESBL-producing E. coli and ESBL-producing K. pneu-
moniae, respectively, carried blaTEM-1. ESBL-producing K.
pneumoniae carried blaSHV at 87.4 % (SHV-1, -2a, -11,
-12, -27, -71, and -75) but only at 3.8 % for ESBL-
producing E. coli (SHV-11 and -12). The blaVEB-1 and
blaOXA-10 were also found in both ESBL-producing E. coli
(8.5 and 8.1 %, respectively) and ESBL-producing K.
pneumoniae (10.2 and 11.8 %, respectively). None of the
isolates were positive for blaPER and blaGES. Pulsed-field
gel electrophoresis (PFGE) analysis demonstrated that
there was no major clonal relationship among these
ESBL isolates.
There are limited data on clinical and molecular epi-
demiology of community-onset (CO) ESBLs in Thailand.
Apisarnthanarak et al. [27], performed a case–control
study to evaluate risk factors for CO-ESBL-producing E
coli infections (n = 46). Controls (n = 138) were patients
without infections. Patients with prior ESBL colonization
and recent antibiotic exposures, especially to third-
generation cephalosporins and fluoroquinolones, were at
risk for CO-ESBL-producing E coli infection. The
plasmid carrying the blaCTX-M-15 gene was identified in
52 %. In addition, evidence of a high prevalence of
ESBL-producing E. coli isolates recovered from
healthy individuals and foods along the food produc-
tion chain from farms to consumers, and in the en-
vironment has been documented in selected areas in
Thailand. Among 544 healthy adult food factory
workers, 906 bacterial isolates were recovered from
rectal swab screening cultures and 75.5 % were posi-
tive for ESBL-producing E. coli. Moreover, 77.3 % of
E. coli isolates collected from 30 healthy animal farm
workers were ESBLs [28].
A. baumannii infections represent a key healthcare
issue in Thailand. Data from the National Antimicrobial
Resistance Surveillance Thailand (NARST) detected a
dramatic increase in CRAB from 2.1 % in 2000 to 46.7 %
in 2005 [29]. Prevalence rates of colonization and infec-
tions of CRAB were reported to be up to 80 % in several
hospitals in Thailand [30, 31]. Infection-related mortality
could be as high as 63.0 % in the patients with A. bau-
mannii bacteremia [31]. In addition, several studies from
tertiary care and academic hospitals in Thailand have
reported a high rate and clonal infection from CRAB
throughout the country [10, 32–35]. CRAB occurs
mainly as a result of the blaOXA gene, and MBL gene ac-
quisition [12, 36]. The blaOXA-23 is a major resistance
determinant among CRAB isolates in Thailand and has
been reported related to global clone 2 [12, 36–38].
The prevalence of MDR-P. aeruginosa clinical isolates
was constant among 28 hospitals participating in the
NARST program in Thailand from 2000 to 2005. The
most common sites of isolation included sputum, pus,
and urine. The prevalence of MDR-P. aeruginosa ranged
from 20 % to 30 % of the isolates [39]. Khuntayaporn et
al. [13] performed susceptibility tests on 261 clinical iso-
lates of MDR-P. aeruginosa (collected during 2007-
2009) from eight tertiary hospitals across Thailand.
Approximately 71.7 % were found to be MDR-P. aerugi-
nosa. The results showed that the meropenem resistance
rate was the highest reaching over 50 % in every hospital.
Additionally, the type of hospital was a major factor affect-
ing the resistance rate, as demonstrated by significantly
higher rates of CRO among university than regional
hospitals. CRPA clinical isolates in Thailand possess multi-
factorial resistance mechanisms [14, 40]. The decreased
expression of OprD mRNA was the most common mech-
anism (93.7 %). This mechanism was associated with the
presence of OprD mutations causing frameshift or transla-
tional stop and the reduction of antibiotic transportation
in to the CRPA cell. MBL production was identified in 24
isolates (18.5 %) and weakly positive in 12 isolates (9.2 %)
including blaIMP-1, blaIMP-14 and blaVIM-2. AmpC β-lacta-
mase hyperproduction had the lowest prevalence rate
(4 %) [14]. This study indicates that the loss of OprD porin
protein was the most common mechanism for imipenem
resistance in P. aeruginosa clinical isolates (98 %) [14]
which is consistent with another study [40].
There are few data on CRE prevalence in Thailand.
However, Rimrang et al. [16], reported the emergence of
NDM-1- and IMP-14a-producing Enterobacteriaceae in
Thailand. A total of 4818 Enterobacteriaceae clinical iso-
lates, collected between October 2010 and August 2011,
were screened for the presence of carbapenemases. The
study revealed 2 other isolates each of Escherichia coli,
Klebsiella pneumoniae and Citrobacter freundii carried
blaNDM-1 and 2 other isolates of K. pneumoniae carried
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blaIMP-14a. The DNA fingerprints revealed that all iso-
lates were different strains except for clonal strains of C.
freundii. All MBL producers were susceptible to colistin
and tigecycline. Interestingly, 6 NDM-producing isolates
were recovered from the urine of 3 patients, who had no
history of travel outside Thailand. Netikul et al. [24],
reported a novel KPC-13-producing CRE in Thailand. In
addition, Kiratisin et al. [41], investigated the genetic
characteristics of plasmid-mediated β-lactamase among
non-Escherichia, non-Klebsiella Enterobacteriaceae that
were non-susceptible to at least a broad-spectrum ceph-
alosporin. From 598 isolates, 143 isolates (23.9 %) were
resistant to a broad-spectrum cephalosporin, amongst
which 142 (99.3 %) and 99 (69.2 %) isolates carried ESBL
and AmpC β-lactamase genes, respectively. The blaKPC
was not detected in isolates with reduced susceptibility
to carbapenems.
Singapore
The largest gram-negative resistance problem in
Singapore hospitals is ESBL-producing Enterobacteria-
ceae particularly Klebsiella spp. and E. coli [1, 5, 6].
ESBL-producing Enterobacteriaceae were first reported
in Singapore in the late 1990s and increased rapidly up
to 35 % - 40 % over time. Similar to observed trends in
other countries, TEM and SHV type ESBLs have spread
to Singapore. These are being replaced by the newer
CTX-M type ESBLs [1, 6]. CTX-M type ESBLs are
currently a major resistance contributor, especially in
nosocomial infections. K. pneumoniae isolates were
found to be carrying genes for CTX-M-9 type and CTX-
M-1 type ESBLs, and E. coli possess a CTX-M-2 type
ESBL. Recently, community associated infections have
also been reported and associated with CTX-M type
ESBLs [6]. Finally, some CTX-M ESBLs may also be
associated with carbapenem resistance in combination
with porin loss or efflux [6, 42]. Nevertheless, a recent
study concluded that the worldwide spread of the gene
for the blaCTX-M-15 is due to epidemic E. coli clones
belonging to Achtman’s MLST 131 and ST405 [43].
In Singapore, carbapenem resistance is more common
in Acinetobacter spp. and P. aeruginosa than in Entero-
bacteriaceae. However, there are several reports of new
CRE genes that have recently been described in clinical
isolates [6, 17, 44]. The discovery of these new genes is
likely related to updated national surveillance data on
CRO and more molecular characterization studies
performed in Singapore compared to other countries in
Southeast Asia. In addition, Singapore is a center of
communication and commercial trading and travelling
in this region. These factors might be also contributed
to the spreading of CROs from travellers [44].
CRAB have emerged as important pathogens in
Singapore since 1990. The prevalence of CRAB has been
increasing over the time [6]. Tan et al. [44] found 98 isolates
of CRAB (70.5 %) from a total of 171 Acinetobacter spp.
isolates (139 A. baumannii isolates) collected from 6 hospi-
tals in Singapore during 2006-2007. The rate of carba-
penem resistance in A. baumannii (70.5 %) was higher than
in other Acinetobacter spp. (25.0 %) [44]. The blaOXA-23
genes were detected in most of the CRAB isolated (91 %)
in a Singapore hospital, while blaIMP-4 and blaOXA-58 genes
were also detected in a few isolates [6, 45].
CRPA has emerged in Singapore during the same time
as CRAB. Tan et al. [45] reported that 11.2 % of 188
isolates of P. aeruginosa collected during 2006–2007
were resistant to meropenem. Nevertheless, like the
situation in other countries, the resistance in CRPA is
related to multifactorial mechanisms. Acquired MBL
genes represented 1.7 % of all P. aeruginosa isolates
collected at Singapore General Hospital during 2001.
The common MBLs in CRPA are blaIMP-1, blaIMP-7, and
blaVIM-6 which also have been previously reported in
Japan, Canada, and Malaysia [6].
Although mechanisms of resistance in CRE seems to
be largely due to non-carbapenamase mechanisms, the
emergence of CRE isolates that carry transferable carba-
penamase genes have been reported from hospital and
community settings in Singapore. MBLs, especially
NDM-1, are a major mechanism of resistance, [6, 17, 22,
44, 46, 47]. Koh et al. [22], reported isolates of K. pneu-
moniae, E. coli, Enterobacter cloacae and Citrobacter
spp. carried a variety of carbapenemase genes including
blaIMP-1, blaIMP-4, blaNDM-1, blaNDM-7, blaOXA-48,
blaOXA-181 and blaKPC-2. Apart from K. pneumoniae with
blaOXA-181, and some K. pneumoniae with blaNDM-1, the
other isolates were not clonal using PFGE analysis. Teo
et al. [17] molecularly characterized 12 NDM-1 producing
clinical Enterobacteriaceae (K. pneumoniae, E. coli, E.
cloacae) isolates from 4 general hospitals in Singapore.
Interestingly, none of the patients had a travel history to
countries where NDM-1 has been reported. None of the
isolates in the Teo study were clonally related using PFGE
analysis [17]. Enterobacteriaceae carrying blaKPC are not
common in Singapore. The first KPC-producing K. pneu-
moniae isolate was reported from a study in 2011. This
isolate carried blaKPC-2 and was identified as Pasteur’s
MLST ST 11 [47].
Vietnam
The Study for Monitoring Antimicrobial Resistance
Trends (SMART 2009–2011) about antimicrobial
susceptibility and ESBL rates in aerobic gram-negative
bacteria causing intra-abdominal infections in Vietnam,
reported high ertapenem MIC90 values for A. bauman-
nii, and P. aeruginosa (>4 μg/mL) [48]. In addition,
among the species collected, E. coli (48.1 % ESBL-
positive) and K. pneumoniae (39.5 % ESBL-positive)
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represented the majority (46.4 %) of the isolates submit-
ted for this study. Ertapenem MIC90 values were lowest
for these 2 species at 0.12 and 0.25 μg/mL and remained
unchanged for ESBL-positive isolates. Imipenem MIC90
values were also the same for all isolates and ESBL-
positive strains at 0.25 and 0.5 μg/mL, respectively [48].
Van et al. [49] performed antimicrobial susceptibility
testing and molecular characterization on 66 A. bau-
mannii complex clinical isolates recovered during 2009
at the National Hospital of Tropical Diseases (NHTD), a
referral hospital in Hanoi, Vietnam. Most isolates were
collected came from lower respiratory tract specimens
from ICU patients. More than 90 % of the isolates were
CRAB. Moreover, 25.4 % were resistant to all tested β-
lactams, quinolones and aminoglycosides. All isolates
remained susceptible to colistin. Unlike CRAB, there is
limited data on CRPA prevalence in Vietnam. A novel
blaIMP-51 has been reported [50]. In Vietnam, NDM-1-
producing E. coli and K. pneumoniae have emerged since
2010. Both organisms were recovered from two patients
admitted to a surgical hospital. These patients had no
history of travel outside Vietnam [20]. In addition, Trung
et al. [19] reported that A. baumannii clinical isolates
carried the ESBL gene (PER-1) and genes from the
blaOXA families (OXA-23, OXA-24 and OXA-58). Inter-
estingly, one A. baumannii that carried blaNDM-1 was re-
covered from a suspected surgical wound infection using
a novel in-house multiplex PCR assay.
Malaysia
In 2009, Lim et al. [51], performed a molecular
characterization on 47 E. coli isolates from various pub-
lic hospitals in Malaysia. All isolates were susceptible to
imipenem whereas 36 (76.6 %) were MDR E. coli (resist-
ant to 2 or more classes of antibiotics). The majority of
ESBL-producing E. coli (87.5 %) harbored the blaTEM
gene. Other ESBL-encoding genes detected were blaOXA,
blaSHV, and blaCTX-M. Integron-encoded integrases
were detected in 55.3 % of isolates. In addition, an-
other study from the same leading author performed
molecular characterization on 51 strains of K. pneu-
moniae isolated from the same hospitals in Malaysia.
The majority of the strains (98 %) were susceptible to
imipenem whereas 27 (52.9 %) were MDR K. pneu-
moniae. Forty-six of the K. pneumoniae strains
harbored blaSHV, 19 harbored blaCTX-M, 5 harbored
blaOXA-1 and 4 harbored blaTEM-1 [52].
Among a total of 54 A. baumannii isolates from the
main tertiary hospital in Terengganu, Malaysia, 39
(72.2 %) were CRAB, whereas 14 (25.9 %) were catego-
rized as extensively drug resistant (XDR) with additional
resistance to polymyxin B [53]. CRPA prevalence in
Malaysia was reported as 21 % [54]. Khosravi et al. [15]
performed molecular characterization on 90 isolates of
imipenem-resistant P. aeruginosa clinical isolates
collected during 2005 to 2008 from the University of
Malaysia Medical Center. A multiplex PCR assay
detected 32 isolates with positive MBL genes including;
blaIMP-7 (12 isolates), blaIMP-4 (2 isolates), blaVIM-2 (17
isolates), and blaVIM-11 (1 isolate). For CRE prevalence
in Malaysia, a total of 321 K. pneumoniae isolates col-
lected during April 2010-June 2012 from academic
hospitals were characterized. Thirteen isolates (4.0 %)
were CRKP and the majority of them were resistant
to all tested antibiotics except colistin and tigecycline.
Among seven different carbapenemase genes studied
(blaKPC, bla IMP, blaSME, blaNDM, blaIMI, blaVIM, and
blaOXA), only blaIMP4 (1.87 %) and blaNDM1 (2.18 %)
were detected in this study [18]. In addition, another
study also confirmed imipenem-resistance in K. pneu-
moniae in Malaysia due to loss of OmpK36 (outer
membrane protein) coupled with AmpC β-lactamase
hyperproduction [25].
Other countries
There are limited data on prevalence and epidemiology
of MDRGN in other countries in Southeast Asia.
Indonesia has rates of ESBLs greater than the overall
APAC average and for most nations in Western Europe
and the United States [1, 5]. In 2011, another study
confirmed a high prevalence of CRO in ICU-Cipto
Mangunkusumo Hospital in Indonesia. The prevalence
of CRE, CRPA and CRAB are 27.6, 21.9, and 50.5 %,
respectively. CRPA harboring the blaIMP-1 gene (5 %)
were isolated from sputum specimens. Moreover,
blaNDM-1 was detected in one K. pneumoniae isolated
from sputum [23]. In the Philippines, an E. coli isolate
carrying blaIMP-26 has been reported [21]. Antibiotic
resistance has been little studied in Laos, where some
antibiotics are available without restriction, but others
such as carbapenems are not available. Stoesser et al. [7]
reported 92 children (23 %) were colonized with ESBL-
producing E. coli carrying blaCTX-M and K. pneumoniae
carrying blaSHV or blaCTX-M, which were frequently re-
sistant to multiple antibiotic classes. Using multivariate
random-effects model, ESBL colonization was associated
with prior antibiotic use within 3 months. Additional
whole genome sequencing studies suggested the trans-
mission of ESBLs in both childcare facilities and com-
munity settings. Tojo et al. [8], reported a case of
CRAB isolates obtained from a returned traveler from
Brunei. This isolate was a second case of A. bauman-
nii harboring blaOxA-23 reported from Japan. There
was no publication on MDRGN reported from
Myanmar and Cambodia.
This review has some limitations. Epidemiology and
prevalence of MDRGN bacteria is a dynamic issue
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worldwide and especially in Southeast Asia. However,
a systematic review could not be performed due to
limitations of available data and the difficulty in
standardizing all data. The lack of international col-
laboration on antimicrobial surveillance studies might
have an effect on the accuracy of the actual preva-
lence of MDRGN bacteria in this region. Molecular
studies on MDRGN bacteria are not routinely per-
formed in microbiology laboratories in several coun-
tries due to limited resources. Lastly, the formal
languages in this region are diverse but we only
reviewed available English literature as is commonly
used for scientific publications.
Conclusions
In summary, MDRGNs are a major contributor of
antimicrobial-resistant bacteria in Southeast Asia.
The high prevalence of ESBLs has been a major
problem since 2005 and is possibly related to the
development of carbapenem resistant organisms in
this region due to the overuse of carbapenem therapy
to treat those infections. Prevalence of CROs in this
region, including CRAB, CRPA and CREs, is rising.
The high prevalence of MDRGNs in the hospital and
community have precipitated development of CROs.
Limited infection control measures, lack of anti-
microbial control, such as the presence of active
antimicrobial stewardship teams in the hospital, and
outpatient antibiotic restrictions, and travel through-
out this region have likely contributed to the increase
in MDRGN prevalence. Thus, improving infection
control practices and laboratory detection, along with
judicious use of antimicrobial agents, and national
surveillance could impact MDRGNs spread in this
region.
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